Search research articles
Contact Us
Filters
Showing results (81-90 of 107) with videos related to
Page
of 11
Sort By:
Journal of Cutaneous Medicine and Surgery
|
March 17, 2015
The Relationship Between Dermatologist- and Patient-Reported Acne Severity Measures and Treatment Recommendations
Jerry Tan, Marc P Frey, Sanja Knezevic, et al.
Journal of Cutaneous Medicine and Surgery
|
November 19, 2010
Canadian hand dermatitis management guidelines
Charles Lynde, Lyn Guenther, Thomas L Diepgen, et al.
The Journal of Allergy and Clinical Immunology
|
August 27, 2019
Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus
Jonathan I Silverberg, Andreas Pinter, Grazyna Pulka, et al.
The Journal of Investigative Dermatology
|
April 21, 2020
TYK2/JAK1 Inhibitor PF-06700841 in Patients with Plaque Psoriasis: Phase IIa, Randomized, Double-Blind, Placebo-Controlled Trial
Seth B Forman, David M Pariser, Yves Poulin, et al.
Dermatology and Therapy
|
April 22, 2021
Psoriasis Prevalence and Severity by Expert Elicitation
Kim A Papp, Robert Gniadecki, Jennifer Beecker, et al.
Journal of Cutaneous Medicine and Surgery
|
March 12, 2019
Checklist for the Systemic Treatment of Psoriasis Using Biologics: A Delphi Study
Christine Fahim, Ben Whan Kim, Marc Bourcier, et al.
Dermatology and Therapy
|
December 23, 2021
Practical and Relevant Guidelines for the Management of Psoriasis: An Inference-Based Methodology
Kim A Papp, Melinda J Gooderham, Charles W Lynde, et al.
Journal of the American Academy of Dermatology
|
October 11, 2017
Adalimumab for nail psoriasis: Efficacy and safety from the first 26 weeks of a phase 3, randomized, placebo-controlled trial
Boni E Elewski, Martin M Okun, Kim Papp, et al.
JAMA Dermatology
|
May 14, 2015
Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis: Results From the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
Robert E Kalb, David F Fiorentino, Mark G Lebwohl, et al.
Journal of Drugs in Dermatology : JDD
|
October 3, 2013
Immune response to pneumococcus and tetanus toxoid in patients with moderate-to-severe psoriasis following long-term ustekinumab use
Carrie Brodmerkel, Eric Wadman, Richard G Langley, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 107) with videos related to
Sort By:
Page
of 11
Journal of Cutaneous Medicine and Surgery
|
March 17, 2015
The Relationship Between Dermatologist- and Patient-Reported Acne Severity Measures and Treatment Recommendations
Jerry Tan, Marc P Frey, Sanja Knezevic, et al.
Journal of Cutaneous Medicine and Surgery
|
November 19, 2010
Canadian hand dermatitis management guidelines
Charles Lynde, Lyn Guenther, Thomas L Diepgen, et al.
The Journal of Allergy and Clinical Immunology
|
August 27, 2019
Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus
Jonathan I Silverberg, Andreas Pinter, Grazyna Pulka, et al.
The Journal of Investigative Dermatology
|
April 21, 2020
TYK2/JAK1 Inhibitor PF-06700841 in Patients with Plaque Psoriasis: Phase IIa, Randomized, Double-Blind, Placebo-Controlled Trial
Seth B Forman, David M Pariser, Yves Poulin, et al.
Dermatology and Therapy
|
April 22, 2021
Psoriasis Prevalence and Severity by Expert Elicitation
Kim A Papp, Robert Gniadecki, Jennifer Beecker, et al.
Journal of Cutaneous Medicine and Surgery
|
March 12, 2019
Checklist for the Systemic Treatment of Psoriasis Using Biologics: A Delphi Study
Christine Fahim, Ben Whan Kim, Marc Bourcier, et al.
Dermatology and Therapy
|
December 23, 2021
Practical and Relevant Guidelines for the Management of Psoriasis: An Inference-Based Methodology
Kim A Papp, Melinda J Gooderham, Charles W Lynde, et al.
Journal of the American Academy of Dermatology
|
October 11, 2017
Adalimumab for nail psoriasis: Efficacy and safety from the first 26 weeks of a phase 3, randomized, placebo-controlled trial
Boni E Elewski, Martin M Okun, Kim Papp, et al.
JAMA Dermatology
|
May 14, 2015
Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis: Results From the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
Robert E Kalb, David F Fiorentino, Mark G Lebwohl, et al.
Journal of Drugs in Dermatology : JDD
|
October 3, 2013
Immune response to pneumococcus and tetanus toxoid in patients with moderate-to-severe psoriasis following long-term ustekinumab use
Carrie Brodmerkel, Eric Wadman, Richard G Langley, et al.
Page
of 11